
Monopoly v. Openness: 2 Sides of IP Coin in the Pharmaceutical Industry
The SSRN website posted an article which noted that the pharmaceutical industry extensively relies on the patent system. It actively lobbies for the strengthening of the patent protection of its medical products. The results of its efforts may be found in bilateral and multilateral agreements. However, some recent developments reflect the emerging tendency
Comments Off on Monopoly v. Openness: 2 Sides of IP Coin in the Pharmaceutical Industry • Read this story »